Kiniksa Pharmaceuticals International (NasdaqGS:KNSA) Q4 2025 Earnings call February 24, 2026 08:30 AM ET Company ParticipantsGeoff Meacham - Managing DirectorJohn Paolini - Chief Medical OfficerJonathan Kirshenbaum - Senior Manager of Investor RelationsMark Ragosa - CFONick Lorusso - VP of Biotech Equity ResearchRoss Moat - COOSanj Patel - CEOConference Call ParticipantsEva Fortea - Executive Director and Senior Biotechnology AnalystJoysree Zanfir - AnalystRoger Song - Senior Equity Research AnalystOperato ...

Kiniksa Pharmaceuticals International (NasdaqGS:KNSA) Q4 2025 Earnings call February 24, 2026 08:30 AM ET Speaker7Reminder, today's program is being recorded. Now I'd like to introduce your host for today's program, Jonathan Kirshenbaum, Investor Relations. Please go ahead, sir.Speaker3Thank you, operator. Good morning, everyone, and thank you for joining Kiniksa's call to discuss our fourth quarter and full year 2025 financial results and recent portfolio execution. A press release highlighting these resul ...